Correlation Between Elevation Oncology and Aclarion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Aclarion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Aclarion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Aclarion, you can compare the effects of market volatilities on Elevation Oncology and Aclarion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Aclarion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Aclarion.

Diversification Opportunities for Elevation Oncology and Aclarion

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Elevation and Aclarion is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Aclarion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclarion and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Aclarion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclarion has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Aclarion go up and down completely randomly.

Pair Corralation between Elevation Oncology and Aclarion

Given the investment horizon of 90 days Elevation Oncology is expected to generate 1.12 times more return on investment than Aclarion. However, Elevation Oncology is 1.12 times more volatile than Aclarion. It trades about 0.13 of its potential returns per unit of risk. Aclarion is currently generating about 0.02 per unit of risk. If you would invest  57.00  in Elevation Oncology on September 1, 2024 and sell it today you would earn a total of  7.00  from holding Elevation Oncology or generate 12.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Elevation Oncology  vs.  Aclarion

 Performance 
       Timeline  
Elevation Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevation Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Aclarion 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Aclarion are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Aclarion may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Elevation Oncology and Aclarion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elevation Oncology and Aclarion

The main advantage of trading using opposite Elevation Oncology and Aclarion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Aclarion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclarion will offset losses from the drop in Aclarion's long position.
The idea behind Elevation Oncology and Aclarion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
CEOs Directory
Screen CEOs from public companies around the world